Aimei Health Technology Right
AFJKR
13 hedge funds and large institutions have $1.46M invested in Aimei Health Technology Right in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
13% less funds holding
Funds holding: 15 → 13 (-2)
49% less capital inflows, than outflows
Capital inflows: $140K | Capital outflows: $276K
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$140K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mangrove Partners
Greenwich,
Connecticut
|
-$270K |
| 2 |
TrueMark Investments
Chicago,
Illinois
|
-$4.46K |
| 3 |
Wolverine Asset Management
Chicago,
Illinois
|
-$761 |
| 4 |
Clear Street
New York
|
-$407 |
| 5 |
Shaolin Capital Management
Miami,
Florida
|
-$153 |
AFJKR Hedge Fund Activity: Q2 2025 in Review
13 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Right (AFJKR) for Q2 2025, worth a combined $1.46M — down 33% from $2.19M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AFJKR and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Toronto Dominion Bank, adding an estimated $140K. The largest seller was Mangrove Partners, exiting entirely with an estimated $270K sold.
- 13 institutional investors held Aimei Health Technology Right (AFJKR) as of Q2 2025, down from 15 in Q1 2025.
- Funds reported $1.46M of Aimei Health Technology Right stock for Q2 2025, down 33% quarter-over-quarter.
- 0 funds opened new Aimei Health Technology Right positions in Q2 2025 and 2 closed out, a net change of -2 holders.
- The largest Aimei Health Technology Right buyer in Q2 2025 was Toronto Dominion Bank, an estimated $140K added.
- The largest Aimei Health Technology Right seller in Q2 2025 was Mangrove Partners, an estimated $270K sold.
Based on aggregated 13F filings for Q2 2025.